Samsara BioCapital »

Neurogene shares owned by Samsara BioCapital

Quarter-by-quarter ownership of Neurogene (NGNE) shares owned by Samsara BioCapital from 13F filings

Historical chart of Samsara BioCapital investment in Neurogene

Tip: Access up to 7 years of quarterly data

All positions including Neurogene held by Samsara BioCapital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurogene by Samsara BioCapital

Quarter filed Position value Share count Share price at filing
2023-12-31 $25M 1.3M 19.38

More positions owned by Samsara BioCapital

Scholar Rock Hldg Corp (SRRK)
Rayzebio
Cargo Therapeutics (CRGX)
Mineralys Therapeutics (MLYS)
Arcellx Common Stock (ACLX)
Neurogene (NGNE)
Graphite Bio
Nkarta (NKTX)
Acelyrin (SLRN)
Zymeworks Del (ZYME)
Lyra Therapeutics (LYRA)
Syros Pharmaceuticals Com New (SYRS)
Avadel Pharmaceuticals Sponsored Adr (AVDL)
Hillevax (HLVX)
Abivax Sa Sponsored Ads (ABVX)

View all positions for Samsara BioCapital

Top funds holding Neurogene

EcoR1 Capital
Samsara BioCapital
Dr. Jeffrey R. Jay, M.D.
Redmile Group
Henderson Group
Cormorant Asset Management
Arrowpoint Asset Management
Casdin Capital
Avidity Partners Management
Baker Bros. Advisors
Walleye Trading Advisors
Nantahala Capital Management
Vanguard Group
Bank of America Corporation
Bessemer

View all funds holding Neurogene